Transmedics Group Inc [NASDAQ: TMDX] surged by $23.47 during the normal trading session on while it closed the day at $117.60.
Transmedics Group Inc stock has also gained 32.31% of its value over the past 7 days. However, TMDX stock has inclined by 37.11% in the 3 months of the year. Over the past six months meanwhile, it has gained 220.09% and gained 48.99% year-on date.
The market cap for TMDX stock reached $3.85 billion, with 32.67 million shares outstanding and 31.48 million shares in the current float. Compared to the average trading volume of 772.29K shares, TMDX reached a trading volume of 4937814 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Transmedics Group Inc [TMDX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TMDX shares is $120.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TMDX stock is a recommendation set at 1.29. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Transmedics Group Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on March 28, 2024. While these analysts kept the previous recommendation, Robert W. Baird raised their target price to Outperform. The new note on the price target was released on July 19, 2023, representing the official price target for Transmedics Group Inc stock. Previously, the target price had yet another raise to $48, while JP Morgan analysts kept a Overweight rating on TMDX stock.
The Average True Range (ATR) for Transmedics Group Inc is set at 6.70, with the Price to Sales ratio for TMDX stock in the period of the last 12 months amounting to 15.93. The Price to Book ratio for the last quarter was 28.00, with the Price to Cash per share for the same quarter was set at 12.07.
TMDX stock trade performance evaluation
Transmedics Group Inc [TMDX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 32.31. With this latest performance, TMDX shares gained by 61.94% in over the last four-week period, additionally plugging by 220.09% over the last 6 months – not to mention a rise of 51.06% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TMDX stock in for the last two-week period is set at 76.49, with the RSI for the last a single of trading hit 81.43, and the three-weeks RSI is set at 72.28 for Transmedics Group Inc [TMDX]. The present Moving Average for the last 50 days of trading for this stock 84.11, while it was recorded at 98.06 for the last single week of trading, and 72.73 for the last 200 days.
Transmedics Group Inc [TMDX]: An insightful look at the core fundamentals
Transmedics Group Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.49 and a Current Ratio set at 9.30.
Earnings per share (EPS) analysis for Transmedics Group Inc [TMDX] stock
With the latest financial reports released by the company, Transmedics Group Inc posted -0.03/share EPS, while the average EPS was predicted by analysts to be reported at -0.13/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 76.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TMDX.
Transmedics Group Inc [TMDX]: Institutional Ownership
The top three institutional holders of TMDX stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in TMDX stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in TMDX stock with ownership which is approximately 5.8386%.
